Copyright ©2026 Investor’s Business Daily, LLC. All rights reserved. 87990cbe856818d5eddac44c7b1cdeb8

Source link

Equities now account for 39.9% of US household net worth, the largest share in Federal Reserve records.

Owners’ equity in residential real estate fell to 19.3% in the same quarter. The gap between the two measures has widened to 20.6 percentage points.

Stocks Pull Away From Housing on the US Household Balance Sheet

The Kobeissi Letter highlighted the diverging figures, which come from the Fed’s quarterly Financial Accounts report.  Households held $185.65 trillion in net worth over the period.

Directly and indirectly held corporate equities accounted for $74.03 trillion of that total. Owners’ equity in residential real estate, which is calculated by subtracting mortgage debt from home values, totaled $35.81 trillion.

The divergence traces back to the last bear market. Equity exposure has climbed 12.6 percentage points since the third quarter of 2022. The housing share lost 3.5 points over the same stretch.

Historically, property held the upper hand. Real estate exposure peaked at 24.1% in the third quarter of 2005, one point above equities.

“Household wealth has never been this skewed toward equities,” the Kobeissi Letter said.

Follow us on X to get the latest news as it happens

Home Prices Stalled While the Nasdaq Set Records

Market returns explain most of the shift. The Nasdaq Composite closed at a record 27,122.09 on September 21, a gain of 16.7% for the year.

The S&P 500 finished the same session at 7,764.70, up 13.4% in 2026. Housing, meanwhile, has barely moved.

The Case-Shiller national home price index rose 1.5% in the year through June. Inflation ran at 3.5% over the same period, leaving home values lower in real terms for the 13th straight month.

Where the gap goes from here depends on what stocks do next. Forecasts for the rest of the year for the S&P 500 range from 7,400 to 8,100. Six of those targets already sit below Monday’s close, while UBS, Citigroup, Oppenheimer, and HSBC top the range.

According to Reuters, Bank of America holds the lowest target at 7,400. That figure implies a decline of roughly 4.7% from Monday’s close. 

The next Financial Accounts release in December will show whether the third quarter widened the gap further.

Subscribe to our YouTube channel to watch leaders and journalists provide expert insights

The post Homes or Stocks? US Households Now Lean on Stocks Like Never Before appeared first on BeInCrypto.

Source link

Bitcoin is trading at $85,954, down 0.8% on the day after briefly tagging $86,922 earlier in the session. That pullback from the highs isn’t noise, it’s happening right inside a supply zone that onchain analysts have flagged as the single biggest test of this recovery’s staying power. What’s underneath that $86K ceiling might determine whether the next leg is $100K or a retreat to the low $80,000s.

The catalyst was $1.26Bn in net inflows into U.S.-listed spot Bitcoin ETFs on Monday, the largest single-day haul in roughly 11 months, with BlackRock’s IBIT alone pulling in $381.4 million.

Glassnode’s latest Market Pulse report shows an estimated 1.07 million BTC were bought between $83,000 and $86,000, with the heaviest cluster sitting near $85,000, supply that had barely moved in 30 days. Roughly $844 million in short positions were liquidated as the price broke the prior $80,000–$82,000 ceiling, according to market recap data.

Falling oil prices and softer Treasury yields have added a risk-on tailwind, but the real story is whether spot demand can absorb sellers who’ve waited months just to break even. That’s the setup worth unpacking.

Can Bitcoin Price Hit $100K This Week?

(Source – TradingView, BTC USD)

BTC’s intraday range has been wide, from a low of $84,082 to a high of $87,373, and the 7-day gain is near 10.75%, per CoinMarketCap’s tracker.

Immediate support clusters around $84,000–$84,786; a break below opens the door to $82,000. Resistance sits at $86,297–$87,000, with the recent spike marking the ceiling so far.

Bull case: ETF inflows persist, the $84K support holds, and a clean break above $87,000 puts $100,000 back on the table.

Base case: consolidation between $84K–$87K as the market digests the 1.07 million BTC of overhead supply near breakeven.

Bear case: a fail below $84,000 triggers stop cascades toward $82,000, especially with Glassnode’s Sell-Side Risk Ratio still elevated relative to July lows.

Full breakdown of the technical picture is available in this Bitcoin breakout analysis, and bearish scenarios are covered in this price prediction piece.

Bitcoin Hyper Targets Early Mover Upside as Bitcoin Tests Key Levels

Anyone holding BTC since the $80K breakout is sitting comfortably. But diminishing returns are the elephant in the room at a $1.7 trillion market cap, a 10x from here isn’t happening. That math is exactly why capital has been rotating into earlier-stage infrastructure plays tied to Bitcoin’s own ecosystem, where upside asymmetry still exists.

Bitcoin Hyper (HYPER) is building the first Bitcoin Layer 2 with SVM integration, targeting execution speeds faster than Solana itself while settling back to Bitcoin’s base layer for security.

The presale has raised $33,149,998.91 at a token price of $0.0136866, with staking rewards live at launch. Its Decentralized Canonical Bridge aims to solve BTC’s two biggest structural gaps, slow transactions and zero programmability, without asking holders to trust a centralized custodian.

Presale tokens carry no guarantee of listing performance, so position sizing matters. More details on how this ties into current BTC price action are in this Bitcoin Hyper presale overview.

Gain Access to New Bitcoin Layer 2 Early Here

Key Takeaways

• Bitcoin holds above $84,000 support with resistance at $86,297–$87,000; a clean break revives the $100,000 narrative.
• A close below $84,000 risks a slide toward $82,000 as 1.07 million BTC near breakeven face renewed sell pressure.
• Bitcoin Hyper’s SVM-powered Layer 2 aims to bring smart contracts and low-cost execution directly to Bitcoin’s ecosystem.
• Continued spot ETF inflows, following Monday’s $998.95 million surge, remain the key catalyst to watch this week.

The post BTC USD Fights For $85K: Bitcoin Price Prediction Says $90K Still in Play appeared first on Cryptonews.

Source link

Source link

Source link

Ethereum has extended its recovery from the September lows and is now trading around $2.73K after slightly breaking above the $2.7K resistance area. The latest move has strengthened the short-term structure, although ETH is approaching another major resistance zone and momentum might be beginning to cool from its recent highs.

Ethereum Price Analysis: The Daily Chart

The daily chart shows a clear structural improvement following the sharp recovery from the $1.5K area. ETH subsequently reclaimed the $1.9K region and then broke above the $2.1K resistance zone with substantial force.

The breakout accelerated in August, pushing ETH above both the 100-day and 200-day moving averages. These key moving averages are now converging rapidly, which could lead to a potential bullish crossover around $2K. All of these signs point to the fact that the broader bearish structure has weakened considerably. Still, a complete long-term trend reversal would require ETH to trade above the higher resistance levels.

The market is currently trading around $2.73K, just above the marked $2.7K resistance zone. Holding above this area could open the way toward the next major resistance around $3.0K. That region is particularly important because it is also an important psychological level that the market would need to overcome.

On the downside, the former $2.7K resistance area could now act as initial support if the breakout holds. Below it, the $2.5K consolidation region is the next notable zone, followed by the key $2.1K support area, which also coincides with the key moving averages.

ETH/USDT 4-Hour Chart

The 4-hour chart provides a clearer view of the latest breakout. ETH spent much of September consolidating between roughly $2.4K and $2.7K before breaking higher over the recent sessions. The move finally carried price through the $2.7K resistance area.

The latest candles show some hesitation after ETH briefly pushed toward $2.8K. This is consistent with profit-taking around a previously marked resistance area rather than an immediate structural reversal.

The key short-term level is now the same $2.7K zone. Holding above this area and completing a pullback would preserve the recent breakout structure and could allow an attempt toward the $3K region. Conversely, a sustained move back below the $2.7K area would weaken the breakout and increase the possibility of a deeper retracement toward the $2.45K bullish order block in the short-term.

The 4-hour RSI has risen into the upper portion of its range following the breakout but has already pulled back from an overbought state. This indicates that momentum remains constructive, while also showing that the market has become less stretched after the initial surge, which is a positive sign showing momentum cooling off before another rally materializes.

Sentiment Analysis

The Ethereum Taker Buy Sell Ratio chart shows the metric’s 30-day average currently around 0.99. A reading below 1 indicates that aggressive taker selling has exceeded aggressive taker buying over the measured period.

This is notable because ETH has continued to appreciate despite the ratio remaining below 1. The latest price rebound therefore has not been accompanied by a clear dominance of aggressive market buying on this metric.

The chart also shows that the 30-day average has been declining from significantly higher levels seen around April and July. At the same time, ETH has recently moved sharply higher from the $1.8K area toward $2.7K. This divergence suggests that the rally has not yet been confirmed by a sustained improvement in taker-buying dominance.

A move in the ratio back above 1, particularly if sustained, would provide stronger confirmation that aggressive futures buyers are gaining control. Conversely, continued readings below 1 while ETH trades near resistance could leave the latest breakout vulnerable to a period of consolidation or correction, especially if spot demand fails to keep up with the selling pressure coming from the futures market.

The post Ethereum (ETH) Price Analysis: Bulls Eye $3K Following Breakout Above $2.7K Resistance appeared first on CryptoPotato.

Source link

Moderna (NASDAQ: MRNA) has remained one of the market’s hottest biotech stocks. Even as the vaccine maker’s shares remain off their 52-week high, hit by news of a breakthrough in using its mRNA technology to create marketable drugs for other diseases and ailments, not just for COVID-19, at around $157 per share, they’re still up over sixfold over the past 12 months.

Yet while Moderna may still be sitting pretty right now, analysts remain skeptical whether the stock can hold on to its latest spate of gains.

Missed AI’s “Act 1”? Act 2 Could Be 15x Bigger. Most investors think they missed the AI boat because they didn’t buy Nvidia in 2005. But according to our analysts, we’re only at the end of “Act 1″—the R&D phase. “Act 2” is the global rollout. Continue »

Moderna, the big rally, and the analyst community’s cautious view

Already trending higher since late 2025, Moderna shares skyrocketed in August. This super rally came on the heels of the company’s unveiling of positive late-stage clinical trial data for Intismeran Autogene, an mRNA-based cancer vaccine that Moderna is co-developing with Merck.

Per the press release, top-line results from the Phase 3 INTerpath-001 trial of Instimeran Autogene combined with Keytruda, Merck’s immunotherapy treatment, “demonstrated meaningful improvements in recurrence-free survival (RFS) and distant metastasis-free survival (DMFS) in patients with completely resected Stage IIB-IV melanoma.”

Advertisement

Perceiving this development as a positive sign for Moderna’s overall plans to bring mRNA-based oncology products to market, Moderna shares surged 177% following the Aug. 19 clinical trial news. Even after giving back some of these gains in the past month, Moderna remains near multiyear highs.

That said, according to Barron’s, most analysts hold either a neutral or “hold” rating on Moderna right now; two analysts have downgraded the stock following this rally. Rothschild & Co. Redburn’s Simon Baker, in his downgrade from “hold” to “sell,” noted that while the phase 3 data were “undoubtedly good,” the market has likely overreacted to news, as it’s uncertain whether the nine other clinical trials for other types of tumors will unveil similar conclusions.

In her bearish research update, J.P. Morgan’s Jessica Fye also noted uncertainty over subsequent trial data, coupled with the argument that the immediate economic implications of the aforementioned clinical trial are already well-factored into the stock price.

The best move for new and existing investors

Advertisement

Story Continues

Investors who bought in before last month’s big news may want to take profits right now, if not exit a Moderna position completely. In the meantime, barring any further clinical trial news, expect more investors to take profits, putting new pressure on shares.

For new investors, considering the specter of a “take profit” sell-off, you may want to sit things out for now. Alongside this risk, it’s worth noting how share dilution remains an issue with Moderna as well.

Following the surge, the company has since raised $2.6 billion in capital by issuing convertible debt. Although convertible at $210.58 per share, these newly issued shares could limit upside in the event Moderna’s pivot continues to propel shares to higher prices.

Advertisement

Moderna could be on its way from being one of the top vaccine stocks to one of the top cancer stocks, but investors may want to wait for the hype to simmer down before entering a long-term position.

Should you buy stock in Moderna right now?

Before you buy stock in Moderna, consider this:

The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Moderna wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.

Consider when Netflix made this list on December 17, 2004… if you invested $1,000 at the time of our recommendation, you’d have $395,625!* Or when Nvidia made this list on April 15, 2005… if you invested $1,000 at the time of our recommendation, you’d have $1,397,147!*

Advertisement

Now, it’s worth noting Stock Advisor’s total average return is 951% — a market-crushing outperformance compared to 214% for the S&P 500. Don’t miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.

See the 10 stocks »

*Stock Advisor returns as of September 22, 2026.

JPMorgan Chase is an advertising partner of Motley Fool Money. Thomas Niel has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends JPMorgan Chase, Merck, and Moderna. The Motley Fool has a disclosure policy.

Advertisement

Should You Buy Moderna Stock? Why Many Wall Street Analysts Say “No.” was originally published by The Motley Fool

Source link

Solana’s x402 protocol has processed roughly $50 billion in volume and connected about 150,000 merchant endpoints, according to a Solana Foundation and Coinbase webinar recap. XRP Ledger has since documented its own x402 implementation settling in XRP and RLUSD, while Cardano remains a name attached to the conversation without comparable live adoption to show for it.

But for smart money, the question isn’t whether AI agents can pay for web resources without a human clicking “checkout.” That part works.

The question is whether any single network converts that technical capability into recurring machine-to-machine commerce that translates into durable demand for its native token, rather than just routing stablecoins through infrastructure that happens to sit on top of it.

How Does x402 Turn HTTP Requests into Payments?

x402 revives an HTTP status code that has sat unused for decades: 402, Payment Required. Instead of a server simply rejecting a request, it responds with pricing terms, letting an AI agent evaluate the cost, authorize a stablecoin payment, and retry the same call with proof of payment attached.

According to the Solana webinar recap, the protocol solves three specific problems for autonomous software: open tool discovery that replaces API keys with a wallet as identity, economic reasoning that embeds live pricing into an agent’s decision-making, and a single runtime where an agent can both earn and spend.

Most transactions settle under 50 cents – a scale of micropayment that traditional card rails were never built to clear economically.

Does x402 Give Solana a Distribution Advantage?

Solana’s pitch leans on infrastructure it already has: more than $15 billion in circulating stablecoins, roughly $10 trillion in cumulative transfers, 400-millisecond block times, and fees near a thousandth of a cent. The recap says x402 has processed over 180 million transactions since launching about a year ago and is now referenced in the docs and workflows of Cloudflare, Stripe, and AWS – the last of which has built it natively into Agent Core Payments.

The webinar’s live demos were the more concrete evidence. Using pay.sh, a Solana-built CLI directory of x402-payable endpoints, an agent located the correct endpoint, paid a one-cent fee, and returned live token-volume rankings without an API key.

A second demo on AWOL, Coinbase’s comparable wallet-based client, chained a social-content pull into a video-generation call, with the agent funding and paying for the entire workflow autonomously – a task the recap notes would otherwise take 30 minutes to an hour of manual key provisioning.

Whether that kind of throughput scales into something with staying power is a separate question from whether Solana’s transaction capacity can handle it, which is the debate Cryptonews has covered in the context of Solana’s transaction stack.

The rival settlement path and the Cardano Credibility Gap

XRP Ledger’s documentation lays out a parallel flow: an agent hits a protected endpoint, receives a 402 response with price and payment address, submits an on-chain XRP or RLUSD payment, and retries once a facilitator verifies the transaction and issues a receipt.

XRPL’s deterministic finality means that verification lands in three to five seconds, according to the documentation – a specific technical claim worth noting given how it differs from Solana’s demo, which is documented separately and dated earlier. For related coverage, see Ripple’s broader push into the Machine Payments Protocol.

Cardano is the hardest case to assess. It’s named as a potential challenger in this market, but nothing in the available evidence shows comparable live transaction volume, merchant endpoints, or agent-payment demonstrations on the network.

That doesn’t rule Cardano out of a longer-term contest – it just means there’s no production adoption to point to yet, which puts it in a different category from Solana’s demoed workflows and XRPL’s documented settlement path.

The broader XRP narrative around AI-driven payment integrations, including XRP’s connection to Stripe-linked payment infrastructure, has already fed into price speculation well ahead of any settled adoption data.

Can micropayments become meaningful network demand?

The Solana recap cites both roughly 200 million and more than 180 million x402 transactions in different passages, without reconciling the two figures or specifying whether either is Solana-exclusive activity.

That’s not a fabrication – the numbers likely reflect different measurement windows or protocol-wide totals rather than network-specific volume – but it’s also not a clean basis for calling this a settled contest between chains.

The deeper structural issue is that x402 and comparable protocols settle in stablecoins, not in SOL, XRP, or ADA. Stablecoins on Solana have already scaled across cross-border payments, remittances, and store-of-value use cases well before agentic payments entered the picture, which means high transaction counts on any of these chains do not automatically translate into equivalent token demand. Fee capture, validator activity, or liquidity effects could eventually matter for native tokens, but the primary evidence here documents payment volume and merchant endpoints, not token-level economic outcomes.

What’s actually being tested here is whether machine-to-machine payments become a recurring commercial pattern or stay confined to conference demos and testnet tutorials.

Solana has the clearest public distribution story right now – real endpoints, real demos, integration references from Cloudflare, Stripe, and AWS.

XRP Ledger has a working settlement path with a specific finality guarantee.

Cardano has neither yet, and until it does, framing this as an even three-way race overstates where the evidence actually sits.

Don’t Miss: The Hottest Meme Coin Opportunities Silently Climbing the Crypto Ranks in September

The post x402’s $50B Scale Gives Solana an AI Payments Edge appeared first on Cryptonews.

Source link

Source link

Source link